Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents

Yong Jian, Gengshen Mo, Weiyuan Xu, Yao Liu, Zhichao Zhang, Yinghui Ding, Ruonan Gao, Jiao Xu, Jiang Zhu, Kun Shu, Zhihan Yan, Fabio Carniato, Carlos Platas-Iglesias, Fangfu Ye, Mauro Botta, Lixiong Dai

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

In recent years, pyclen-based complexes have attracted a great deal of interest as magnetic resonance imaging (MRI) contrast agents (CAs) and luminescent materials, as well as radiopharmaceuticals. Remarkably, gadopiclenol, a Gd(III) bishydrated complex featuring a pyclen-based heptadentate ligand, received approval as a novel contrast agent for clinical MRI application in 2022. To maximize stability and efficiency, two novel chiral pyclen-based chelators and their complexes were developed in this study. Gd-X-PCTA-2 showed significant enhancements in both thermodynamic and kinetic stabilities compared to those of the achiral parent derivative Gd-PCTA. 1H NMRD profiles reveal that both chiral gadolinium complexes (Gd-X-PCTA-1 and Gd-X-PCTA-2) have a higher relaxivity than Gd-PCTA, while variable-temperature 17O NMR studies show that the two inner-sphere water molecules have distinct residence times τMa and τMb. Furthermore, in vivo imaging demonstrates that Gd-X-PCTA-2 enhances the signal in the heart and kidneys of the mice, and the chiral Gd complexes exhibit the ability to distinguish between tumors and normal tissues in a 4T1 mouse model more efficiently than that of the clinical agent gadobutrol. Biodistribution studies show that Gd-PCTA and Gd-X-PCTA-2 are primarily cleared by a renal pathway, with 24 h residues of Gd-X-PCTA-2 in the liver and kidney being lower than those of Gd-PCTA.

Lingua originaleInglese
pagine (da-a)8462-8475
Numero di pagine14
RivistaInorganic Chemistry
Volume63
Numero di pubblicazione18
DOI
Stato di pubblicazionePubblicato - 6 mag 2024

Fingerprint

Entra nei temi di ricerca di 'Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents'. Insieme formano una fingerprint unica.

Cita questo